PortfoliosLab logo

Celularity Inc. (CELU)

Equity · Currency in USD · Last updated Aug 6, 2022

Company Info

ISINUS1511901050
CUSIP151190105
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$3.02
Year Range$2.80 - $12.91
EMA (50)$4.55
EMA (200)$6.35
Average Volume$640.30K
Market Capitalization$429.94M

CELUShare Price Chart


Chart placeholderClick Calculate to get results

CELUPerformance

The chart shows the growth of $10,000 invested in Celularity Inc. in Aug 2019 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $3,082 for a total return of roughly -69.18%. All prices are adjusted for splits and dividends.


-50.00%0.00%50.00%100.00%150.00%MarchAprilMayJuneJulyAugust
-36.95%
-9.64%
CELU (Celularity Inc.)
Benchmark (^GSPC)

CELUReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M-18.60%8.19%
6M-32.59%-7.42%
YTD-41.02%-13.03%
1Y-65.17%-5.85%
5Y-32.53%12.19%
10Y-32.53%12.19%

CELUMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2022-12.11%59.56%21.31%34.21%-21.13%-63.12%-11.47%0.33%
2021-7.18%-0.98%-0.30%0.30%0.20%0.49%-13.56%-3.98%-16.21%-4.66%-4.59%-20.50%
20200.90%0.00%-2.39%1.17%-0.25%3.13%-0.39%1.87%1.45%-2.86%2.35%5.36%
20190.00%1.53%-1.01%0.81%0.20%

CELUSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Celularity Inc. Sharpe ratio is -0.57. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-0.500.000.501.00MarchAprilMayJuneJulyAugust
-0.57
-0.31
CELU (Celularity Inc.)
Benchmark (^GSPC)

CELUDividend History


Celularity Inc. doesn't pay dividends

CELUDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2022FebruaryMarchAprilMayJuneJulyAugust
-76.61%
-13.58%
CELU (Celularity Inc.)
Benchmark (^GSPC)

CELUWorst Drawdowns

The table below shows the maximum drawdowns of the Celularity Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Celularity Inc. is 78.31%, recorded on Aug 4, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-78.31%Apr 29, 202267Aug 4, 2022
-68.64%Jul 20, 2021127Jan 18, 202264Apr 20, 2022191
-33.44%Dec 24, 2020139Jul 15, 20212Jul 19, 2021141
-7.75%Apr 21, 20223Apr 25, 20223Apr 28, 20226
-6.36%Feb 18, 202022Mar 18, 202065Jun 19, 202087
-6.28%Dec 14, 20205Dec 18, 20203Dec 23, 20208
-4.5%Sep 15, 202037Nov 4, 202024Dec 9, 202061
-2.21%Jul 28, 20204Jul 31, 20202Aug 4, 20206
-1.64%Aug 5, 20203Aug 7, 202018Sep 2, 202021
-1.47%Jul 1, 20204Jul 7, 20207Jul 16, 202011

CELUVolatility Chart

Current Celularity Inc. volatility is 91.61%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%50.00%100.00%150.00%200.00%250.00%300.00%MarchAprilMayJuneJulyAugust
91.61%
19.67%
CELU (Celularity Inc.)
Benchmark (^GSPC)